Exhibit 10.10


 


EMPLOYMENT
AGREEMENT


 


EMPLOYMENT
AGREEMENT (the “Agreement”), dated January 30, 2020 (the “Effective Date”), by and between Brain Scientific
Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”), and Boris (Baruch)
Goldstein (the “Executive”).


 


WITNESSETH:


 


WHEREAS,
the Executive has previously been appointed as the Chairman of the Board of the Company and as its Executive Vice President and
Secretary; and


 


WHEREAS,
the Company and the Executive are desirous of memorializing the terms and conditions of the Executive’s employment on the
terms and subject to the conditions hereinafter set forth.


 


NOW,
THEREFORE, for and in consideration of the mutual covenants contained herein, the parties hereto agree as follows:


 


1.
EMPLOYMENT OF EXECUTIVE. Subject to the terms and conditions of this Agreement, the Company hereby agrees to continue to
employ the Executive, and the Executive hereby accepts such continuation of employment in the position of Executive Vice President
and Secretary of the Company.


 


2.
DUTIES. The Executive shall render, on a part-time basis as reasonably determined by the Company and the Executive from
time to time, as an employee, professional services as the Executive Vice President and Secretary (the “Position”),
with duties consistent therewith of a public corporation with subsidiaries and as may be assigned to the Executive by the Board
of Directors of the Company (the “Board”) from time to time in accordance with the foregoing (collectively, the “Duties”),
and shall comply with such reasonable policies, standards and regulations of the Company as are from time to time established
by the Company for its senior executives. The Executive shall perform all of his Duties to the best of his professional ability.
It shall not be a violation of this Agreement for the Executive to (i) serve on industry trade, civic or charitable boards or
committees, (ii) manage his personal investments and affairs; and (iii) serve as an employee, executive or on the board of directors
of, any other for-profit enterprise, so long as in each case, such activity does not materially interfere with the Executive’s
Duties hereunder or is in violation of Section 13 hereof. For so long as the Executive is in the Position, the Company shall nominate
the Executive to the Board and shall be the Chairman of the Board.


 


3.
TERM. The Executive shall be employed from the Effective Date until terminated pursuant to the termination provisions set
out in Section 12 of this Agreement (the “Term”). At the end of the Term (as defined below) or otherwise upon the
termination of Executive’s employment with the Company for any reason, Executive shall be deemed to have resigned from any
and all director positions he has with the Company and its subsidiaries and affiliates, and from any and all of his executive
and other employment roles with the Company’s subsidiaries and affiliates.


 






     


     


    

 


4.
PLACE OF EMPLOYMENT. Services performed by the Executive pursuant to this Agreement shall be performed at the Company’s
U.S. headquarters in New York, New York, or such place(s) as shall be mutually agreeable to the Company and Executive. The Executive
understands and agrees that he may be required to travel to other destinations from time to time, as reasonably necessary to fulfill
the Duties.


 


5.
COMPENSATION. For all services rendered to the Company, the Company shall provide Executive as total compensation a sum
computed as set forth in this Section 5.


 


	 	(a)	Base
    Salary. During the Term, the Executive shall receive an annual base salary (the “Annual Base Salary”) equal
    to $180,000 per year, which shall be paid in accordance with the Company’s normal payroll practices for senior executive
    officers of the Company as in effect from time to time. During the Term, the Annual Base Salary shall be reviewed at least
    annually, and may be increased but not decreased by the Compensation Committee of the Board or the Board if there be no such
    Compensation Committee (in either case, the “Committee”). The term “Annual Base Salary” as utilized
    in this Agreement shall refer to the Annual Base Salary as so adjusted.


 


	 	(b)	Annual
    Bonus. In addition to the Annual Base Salary, for each fiscal year commencing from the Effective Date and ending during
    the Term, the Executive shall be eligible for an annual cash bonus (the “Annual Bonus”) equal to a target of 50%
    of the Annual Base Salary (the “Target Bonus”). The Target Bonus will be earned in any given year in respect of
    which the Company achieves certain performance metrics and goals as may be determined by the Committee in consultation with
    the Executive prior to or promptly following the beginning of each fiscal year. Each such Annual Bonus awarded to the Executive
    shall be paid sometime during the first seventy-five (75) days of the fiscal year next following the fiscal year for which
    the Annual Bonus is awarded. Executive must be employed with the Company in good standing on the last day of the fiscal year
    with respect to which the Annual Bonus relates to earn and be eligible to receive the Annual Bonus.


 


	 	(c)	Option
    Grant. During the Term, the Executive shall be entitled to participate in any stock option, performance share, performance
    unit or other equity based longterm incentive compensation plan, program or arrangement (the “Plans”) generally
    made available to senior executive officers of the Company, on substantially the same terms and conditions as generally apply
    to such other officers, except that the size of the awards made to the Executive shall reflect the Executive’s position
    with the Company. [In furtherance of the foregoing, promptly after the Effective Date, the Company shall grant to the Executive
    options to purchase 800,000 shares of the Company’s common stock (the “Options”) at an exercise price equal
    to the fair market value of the Company’s common stock on the date of grant (which fair market value as of the date
    hereof is $0.75), and which Options shall vest ratably on a quarterly basis over the following two years, all subject to the
    terms and conditions of the applicable Plan and/or award agreements (collectively, together with any additional Plans and
    agreements awarding the Executive equity or equity-based awards, the “Equity Documents”).]


 






    2


     


    

 


	 	(d)	Recoupment
    of Unearned Incentive Compensation. If the Company restates all or a portion of its financial statements for any given
    fiscal year, the Board or committee thereof may require reimbursement of any bonus or incentive compensation paid to the Executive
    for such fiscal year if and to the extent that (i) the amount of such incentive compensation for such fiscal year was calculated
    based upon the achievement of certain financial results that were subsequently reduced due to a restatement, (ii) the Executive
    engaged in any fraud or misconduct that caused or significantly contributed to the need for the restatement, and (iii) the
    amount of the bonus or incentive compensation that would have been awarded to the Executive for such fiscal year had the financial
    results been properly reported would have been lower than the amount actually awarded.


 


6.
VACATION/SICK TIME. The Executive shall be entitled to vacation time in accordance with the Company’s policies in
effect from time to time, with full pay, of four (4) weeks (twenty (20) working days), during each full year of Executive’s
employment. Unused vacation days shall be forfeited at the end of each calendar year and shall not roll over to the next year,
nor will Executive be paid for any unused vacation days in a calendar year; provided, however, that upon termination of Executive’s
employment for any reason, the Company will pay any accrued or unused and unpaid vacation time. The Executive shall be granted
sick time in accordance with the Company’s policy in effect from time to time.


 


7.
REIMBURSEMENT OF BUSINESS EXPENSES. The Company shall reimburse Executive for expenses reasonably incurred during the course
of Executive’s employment, including travel expenses. Such reimbursement shall be made in accordance with Company policies
in effect from time to time upon presentation of receipts and such other reasonable additional substantiation and justification
to the Company for expenses actually incurred in connection with the foregoing.


 


8.
ADDITIONAL BENEFITS. The Executive and his dependents shall be eligible to participate in the Company’s benefits
plans available to its employees from time to time in accordance with the terms and conditions of such plans. The Company reserves
the right to alter, amend, replace or discontinue the benefit plans it makes available to its employees (including the Executive),
at any time, with or without notice.


 


9.
COMPANY PROPERTY DEFINED. The Executive acknowledges and understands that Company files, customer files, legal files, legal
research files, form files, forms, examples, samples, notes, drawings, designs, logos, inventions, improvements, developments,
discoveries, ideas, trade secrets and all briefs and memoranda, intellectual property and other work product or property, and
all copies thereof (the “Company Property”) are the sole and exclusive property of the Company; and the Company Property
shall remain in the possession of the Company and shall constitute the property of the Company irrespective of who prepared the
Company Property. The Executive shall not remove, photocopy, photograph or in any other manner duplicate or remove said Company
Property other than in the performance of his Duties for or on behalf of the Company. The provisions of this Section 9 shall survive
the termination of this Agreement and the Executive’s employment with the Company.


 






    3


     


    

 


10.
DISPOSITION OF PROPERTY UPON TERMINATION OF EMPLOYMENT. In the event the employment of the Executive with the Company is
terminated, the Executive shall promptly return to the Company all Company Property in his possession or control, and the Executive
shall have no right, title or interest in the same. The provisions of this Section 10 shall survive the termination of this Agreement
and the Executive’s employment with the Company.


 


11.
OWNERSHIP OF PATENTS AND INTELLECTUAL PROPERTY.


 


	 	(a)	Any
    work prepared for the Company during the course of the Executive’s employment by the Company that is eligible for copyright,
    patent and/or trademark protection under the laws of the United States or any other country and any proprietary know-how developed
    by Executive (solely or jointly with others) while rendering services for the Company will vest in the Company. Executive
    hereby grants, transfers and assigns all right, title and interest in such work and all copyrights, patents and trademarks
    in such work and all renewals and extensions thereof to the Company, all of which shall be deemed a work for hire for the
    Company under the U.S. Copyright Act to the fullest extent permitted under the law, and Executive shall provide all assistance
    reasonably requested by the Company in the establishment, preservation and enforcement of the Company’s copyright, patents
    and trademarks in such work, such assistance to be provided at the Company’s expense but without any additional compensation
    to Executive. If the Company cannot, after reasonable effort, secure Executive’s signature on any documents needed to
    apply for or prosecute any patent, copyright, trademark or other right or protection relating to an invention, whether because
    of Executive’s physical or mental incapacity or for any other reason whatsoever, Executive hereby irrevocably designates
    and appoints the Company and its duly authorized officers and agents as Executive’s agent and attorney-in-fact, to act
    for and on Executive’s behalf and in Executive’s name and stead for the purpose of executing and filing any such
    application or applications and taking all other lawfully permitted actions to further the prosecution and issuance of patents,
    copyrights, trademarks or similar protections thereon, with the same legal force and effect as if executed by Executive.


 


	 	(b)	Executive
    agrees that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings, designs,
    logos, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, authored, invented,
    developed or reduced to practice by Executive, solely or in collaboration with others, during the period of time Executive
    is in the employ of the Company (including during off-duty hours), or with the use of Company’s equipment, supplies,
    facilities, or Company Confidential Information, and any copyrights, patents, trade secrets, mask work rights or other intellectual
    property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company.
    Executive also agrees to promptly make full written disclosure to the Company of any Inventions, and to deliver and assign
    and hereby irrevocably assigns fully to the Company all of Executive’s right, title and interest in and to Inventions.
    Executive agrees that this assignment includes a present conveyance to the Company of ownership of Inventions that are not
    yet in existence.


 


	 	(c)	The
    provisions of this Section 11 shall survive the termination of this Agreement and the Executive’s employment with the
    Company.


 






    4


     


    

 


12.
TERMINATION OF EMPLOYMENT. The employment of the Executive may be terminated as follows:


 


	 	(a)	Termination
    on Notice. Subject to the remaining clauses of this Section 12, either party shall have the right to earlier terminate
    Executive’s employment under this Agreement at any time for any reason or no reason upon one (1) month prior written
    notice. In the event that the Company or Executive gives notice to terminate pursuant to the foregoing sentence, the Company
    may elect to have Executive cease working immediately so long as the Company continues to pay Executive’s Annual Base
    Salary in accordance with the provisions of Section (5)(a) and the Executive continues to participate in all employee benefit
    plans, for the entire one (1) month notice period (such payment, the “Continuation Pay”). In the event the Company
    elects to have Executive immediately cease working during the one (1) month notice period as provided in the foregoing sentence
    and Executive finds alternative employment that is not in violation of any provision herein, including, without limitation,
    Section 13 hereof, Executive may accept and engage in the alternative employment without forfeiting the Continuation Pay.


 


	 	(b)	Termination
    by the Company for Cause. The Company may terminate this Agreement and the Executive’s employment hereunder for
    Cause (as defined below) at any time during the Term. For purposes of this Agreement, “Cause” shall mean the Executive’s:
    (i) conviction of any felony or any other crime involving dishonesty or moral turpitude; (ii) commission of any act of fraud
    or theft of or maliciously intentional damage to the property of the Company or any of its subsidiaries or affiliates; (iii)
    willful or intentional breach of his fiduciary duties to the Company of any written Company policy, plan or code then in effect;
    or (iv) breach of any material provision of this Agreement. Notwithstanding the foregoing, prior to any termination by the
    Company of the Executive’s employment for Cause, (x) the Company shall first provide written notice to the Executive
    setting forth in reasonable detail the specific conduct of the Executive purporting to constitute Cause (the “Cause
    Notice”) within ninety (90) days of the date the Board first becomes aware of its existence, (y) the Executive shall
    have the opportunity to cure or remedy such act or default within thirty (30) days following such Cause Notice, and (z) the
    Company shall terminate the Executive’s employment within ninety (90) days following any such failure to cure by the
    Executive.


 






    5


     


    

 


	 	(c)	Termination
    by the Executive for Good Reason. The Executive may terminate this Agreement and Executive’s employment hereunder
    with Good Reason (as defined below) at any time during the Term. For purposes of this Agreement, “Good Reason”
    shall mean: (i) the reduction of the Executive’s title, authority, Duties or responsibilities; (ii) any reduction in
    Annual Base Salary or Target Bonus potential of the Executive; (iii) breach of any material provision of this Agreement or
    the Equity Documents by the Company or its subsidiaries or affiliates, as applicable or (iv) any relocation of the Executive’s
    principal place of employment to a location more than thirty (30) miles away from the Executive’s principal place of
    employment as of the Effective Date. Notwithstanding the foregoing, prior to any termination by the Executive of the Executive’s
    employment for Good Reason, (x) the Executive shall first provide written notice to the Company setting forth in reasonable
    detail the specific conduct of the Company purporting to constitute Good Reason (the “GR Notice”) within ninety
    (90) days of the date the Executive first becomes aware of its existence, (y) the Company shall have the opportunity to cure
    or remedy such act or default within thirty (30) days following such GR Notice, and (z) the Executive shall terminate the
    Executive’s employment within ninety (90) days following any such failure to cure by the Company.


 


	 	(d)	Termination
    by Death. If the Executive dies while employed under this Agreement, this Agreement shall terminate immediately and the
    Company shall pay to the Executive’s estate any earned Annual Base Salary, earned but unpaid Annual Bonus for the year
    prior to the year of termination (the “Prior Year Bonus”), a pro-rated Target Bonus for the year of termination,
    if any, based on the number of days employed in such year (the “Pro-Rated Bonus”), reimbursement of business expenses
    and accrued vacation, if any, that is unpaid up to the date of his death.


 


	 	(e)	Termination
    by Disability. The Company may terminate this Agreement as a result of any mental or physical disability or illness which
    results in (i) the Executive being unable to substantially perform his duties for a continuous period of 150 days or for periods
    aggregating 180 days within any period of 365 days or (ii) the Executive being subject to a permanent or indefinite inability
    to perform essential functions based on the reasonable opinion of a qualified board-certified medical doctor chosen in good
    faith by the Company. Termination will be effective on the date designated by the Company, and the Executive will be paid
    any unpaid earned Annual Base Salary, the Prior Year Bonus, the Pro-Rated Bonus if any, reimbursement of business expenses
    and accrued vacation, if any, and benefits as set out in Section 8, in each case as accrued through the date of termination.


 


	 	(f)	Payment
    upon Termination for Cause or without Good Reason. Upon Executive’s termination of employment for Cause, or if Executive
    shall terminate without Good Reason, Executive shall forfeit the right to receive any and all further payments hereunder,
    other than the right to receive any unpaid earned Annual Base Salary, the Prior Year Bonus, reimbursement of business expenses
    and accrued vacation, if any, and benefits as set out in Section 8, in each case as accrued through the date of termination.


 






    6


     


    

 


	 	(g)	Payment
    Upon Termination without Cause or for Good Reason. In the event of the termination of the Executive’s employment
    by the Company without Cause or upon the Executive’s termination of his employment for Good Reason, (i) all amounts
    of Annual Base Salary accrued but unpaid as of the termination date shall be paid by the Company within thirty (30) days following
    the date of termination, (ii) an amount equal to (x) the Executive’s Annual Base Salary on the date of termination for
    a period of twenty four (24) months (or sixty (60) months if the termination without Cause or for Good Reason occurs within
    twenty four (24) months after a Change in Control (as defined below), subject to Section 12(i) below) plus (y) the Target
    Bonus for the year of termination, if any, shall be paid by the Company in twenty four (24) equal monthly installments, (iii)
    100% of any unvested portion of outstanding option grants shall immediately vest and become exercisable and shall remain exercisable
    for the periods specified in each such option; (iv) the Prior Year Bonus shall be paid at such time as such bonus would otherwise
    be payable pursuant to Section 5(b); (v) the dollar value of unused and accrued vacation days and reimbursement of business
    expenses shall be paid within thirty (30) days following the date of termination; and (vi) the applicable premiums (inclusive
    of premiums for Executive’s dependents) shall be paid by the Company pursuant to the Consolidated Omnibus Budget Reconciliation
    Act of 1986, as amended, for twelve (12) months from the date of termination for any benefits plan sponsored by the Company.
    For purposes of this Agreement, “Change in Control” shall mean the occurrence of any of the following after the
    Effective Date: (i) an acquisition of the Company by another person or entity by means of any transaction or series of related
    transactions to which the Company is a party (including, without limitation, a merger, consolidation or other corporate reorganization),
    other than an acquisition in which the shares of capital stock held by stockholders of the Company immediately prior to such
    acquisition continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately
    after such acquisition and by virtue of the acquisition, a majority of the total outstanding voting power of the surviving
    or acquiring person or entity; (ii) a sale, lease, exclusive license (unless granted in the ordinary course of business) or
    other disposition of all of substantially all of the assets of the Company, except where such sale, lease, exclusive license
    or other disposition is to a wholly owned subsidiary of the Company; or (iii) a transaction or series of related transactions
    to which the Company is a party (whether by merger, consolidation, stock acquisition or otherwise) in which a majority of
    the total outstanding voting power of the Company is transferred. Notwithstanding the foregoing sentence, a transaction shall
    not constitute a Change of Control if the primary purpose is to change the jurisdiction of the Company’s incorporation,
    create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s
    securities immediately before such transaction, or engage in a bona fide equity financing transaction.


 






    7


     


    

 


	 	(h)	Deferred
    Compensation. This Agreement is intended to comply with or be exempt from Section 409A of the Internal Revenue Code of
    1986, as amended (the “Code”) and will be interpreted, administered and operated in a manner consistent with that
    intent. Notwithstanding anything herein to the contrary, if at the time of the Executive’s separation from service with
    the Company he is a “specified employee” as defined in Section 409A of the Code (and the regulations thereunder)
    and any payments or benefits otherwise payable hereunder as a result of such separation from service are subject to Section
    409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without
    any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is six months
    following the Executive’s separation from service with the Company (or the earliest date as is permitted under Section
    409A of the Code), and the Company will pay any such delayed amounts in a lump sum at such time. If any other payments of
    money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under
    Section 409A of the Code, such payments or other benefits shall be deferred if deferral will make such payment or other benefits
    compliant under Section 409A of the Code, or otherwise such payment or other benefits shall be restructured, to the extent
    possible, in a manner, determined by the Company, that does not cause such an accelerated or additional tax. To the extent
    any reimbursements or in-kind benefits due to the Executive under this Agreement constitute “deferred compensation”
    under Section 409A of the Code, any such reimbursements or in-kind benefits shall be paid to the Executive in a manner consistent
    with Treas. Reg. Section 1.409A-3(i)(1)(iv). Each payment made under this Agreement shall be designated as a “separate
    payment” within the meaning of Section 409A of the Code. References to “termination of employment” and similar
    terms used in this Agreement are intended to refer to “separation from service” within the meaning of Section
    409A of the Code to the extent necessary to comply with Section 409A of the Code. In no event may the Executive, directly
    or indirectly, designate the calendar year of any payment to be made under this Agreement. Any provision in this Agreement
    providing for any right of offset or set-off by the Company shall not permit any offset or set-off against payments of “non-qualified
    deferred compensation” for purposes of Section 409A of the Code or other amounts or payments to the extent that such
    offset or set-off would result in any violation of Section 409A or adverse tax consequences to the Executive under Section
    409A.


 


	 	(i)	Parachute
    Payments. In the event that the severance and other benefits provided to the Executive pursuant to this Agreement (A)
    constitute “parachute payments” within the meaning of Section 280G of the Code and (B) but for this Section 12(i),
    such severance and benefits would be subject to the excise tax imposed by Section 4999 of the Code, then the Executive’s
    severance benefits under this Section shall be payable either: (y) in full, or (z) as to such lesser amount which would result
    in no portion of such severance and other benefits being subject to excise tax under Section 4999 of the Code, whichever of
    the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed
    by Section 4999, results in the receipt by the Executive on an after-tax basis, of the greatest amount of severance benefits
    under this Agreement. Unless the Company and the Executive otherwise agree in writing, any determination required under this
    Section 12(i) shall be made in writing by independent public accountants reasonably agreed to by the Company and the Executive
    (the “Accountants”), whose determination shall be conclusive and binding upon the Executive and the Company for
    all purposes. For purposes of making the calculations required by this Section 12(i), the Accountants may make reasonable
    assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning
    the application of Section 280G and 4999 of the Code. The Company and the Executive shall furnish to the Accountants such
    information and documents as the Accountants may reasonably request in order to make a determination under this Section. The
    Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this
    Section 12(i).


 






    8


     


    

 


13.
RESTRICTIVE COVENANTS.


 


	 	(a)	Noncompetition.
    During the Term and for the twenty four (24) month period immediately following the termination of employment, regardless
    of the reason for such termination and regardless whether this Agreement has terminated or expired (the “Restricted
    Period”), Executive shall not, directly or indirectly: (i) engage in, manage, operate, control, supervise, or participate
    in the management, operation, control or supervision of any company or entity that competes with any business of the Company
    or any of its subsidiaries (a “Competitor”, as further defined below) or serve as an employee, consultant or in
    any other capacity for a Competitor; (ii) have any ownership or financial interest, directly, or indirectly, in any Competitor
    including, without limitation, as an individual, partner, shareholder (other than as a shareholder of a publicly-owned corporation
    in which the Executive owns less than two percent (2%) of the outstanding shares of such corporation), officer, director,
    employee, principal, agent or consultant; or (iii) serve as a representative of any Competitor; provided, that if the Executive
    provides services to a multi-strategy organization that includes a unit, division, subsidiary or affiliate (any of which,
    a “Unit”) that engages in a Competitor business, but the Executive does not, directly or indirectly, provide services
    to the Unit that is engaged in the Competitor business, then the Executive shall not be in violation of this Section 13(a);
    provided that the Executive puts up a “chinese wall” between the Unit he works in or for and the Unit engaging
    in the Competitor business which shall be approved in the reasonable discretion of the Company. For the purposes of this Agreement,
    “Competitor” shall further mean any company or entity, whether located in the United States, Canada or elsewhere,
    that engages in (i) the supply, commercialization, development, manufacture and/or distribution of solutions to the neurology
    market and neurological diagnostic devices or (ii) other developments that the Company has taken material measures toward
    executing as of the termination date from any of its assets.


 


	 	(b)	Non-Solicitation;
    No-Hire. Executive acknowledges and agrees that during the Restricted Period he shall not, directly or indirectly, other
    than in connection with carrying out his Duties hereunder, (i) solicit or induce any employee or consultant of the Company
    (or any individual who was an employee or consultant of the Company at any time during the 12-month period preceding any such
    solicitation or inducement) to (A) terminate his employment or relationship with the Company, and/or (B) work for the Executive
    or any Competitor; provided that the foregoing shall not be violated by general solicitation not targeted at the prohibited
    group or by the Executive serving as a reference upon request or (ii) hire, or be involved in the process of any business,
    entity or division in hiring, any employee or consultant of the Company (or any individual who was an employee or consultant
    of the Company at any time during the 12-month period preceding any such hiring); provided that Executive shall not be prohibited
    from employing any person who is no longer an employee of the Company as of the date of first contact by Executive so long
    as the termination of such person’s employment with the Company was effectuated for a good faith, bona fide reason and
    was not intended to be a sham or artifice to avoid the restrictions contained in this Section 13(b).


 






    9


     


    

 


	 	(c)	Non-Solicitation
    of Clients. Executive acknowledges and agrees that during the Restricted Period he shall not, directly or indirectly,
    solicit, take away or divert, or attempt to solicit, take away or divert, the business or patronage of any client or customer
    of the Company with the intention or for the purpose of providing services that compete with the services provided by the
    Company at the time of Executive’s termination.


 


	 	(d)	Disparaging
    Comments. Executive agrees not to make critical, negative or disparaging remarks about the Company or its management,
    business or employment practices; provided that nothing in this Section 13(d) shall be deemed to prevent the Executive from
    responding fully and accurately to any question, inquiry or request for information when required by applicable law or legal
    process, or to enforce this Agreement. The Company and its officers and directors shall not make critical, negative or disparaging
    remarks about the Executive; provided that nothing in this Section 13(d) shall be deemed to prevent the Company or its officers
    or directors from (i) responding fully and accurately to any question, inquiry or request for information when required by
    applicable law or legal process, (ii) complying with the disclosure requirements under the federal securities laws or any
    applicable stock exchange or quotation system, or (iii) to enforce this Agreement.


 






    10


     


    

 


	 	(e)	Confidentiality.
    The Executive acknowledges and agrees that the Company’s business is highly competitive and that the Executive will
    be involved in and become aware of the Company’s trade secrets, materials, know-how (whether or not in writing), technology,
    product information and intellectual property belonging to the Company (“Trade Secrets”) and all confidential
    matters (whether available in written, electronic form or orally) relating to the Company and its business (including without
    limitation its strategies, models, business and marketing plans, pricing, sales and revenue information, financial performance,
    etc.), and personal and other confidential information relating to its owners, directors, officers, investors, shareholders,
    executives and employees (the “Confidential Information”), all of which have been developed at great investment
    of time and resources by the Company so as to engender substantial good will, and all of which are and will remain the exclusive
    property of the Company. Therefore, the Executive agrees that during the period of his employment with the Company and at
    all times thereafter, Executive shall not disclose, shall keep secret, shall retain in strictest confidence and shall not
    use for his benefit or the benefit of others, except in connection with the business and affairs of the Company, any Trade
    Secret or Confidential Information. Nothing in this Agreement or elsewhere shall prevent the Executive from: (i) cooperating
    with, or participating in, any investigation conducted by any governmental agency; (ii) making truthful statements, or disclosing
    documents and information, (x) to the extent reasonably necessary in connection with any litigation, arbitration or mediation
    involving his rights or obligations under this Agreement or otherwise or (y) when and to the extent required by law, legal
    process or by any court, arbitrator, mediator or legislative body (including any committee thereof) with actual or apparent
    jurisdiction to order him to make such statements or to disclose or make accessible such documents and information; (iii)
    retaining, and using appropriately (e.g., not in connection with violating any non-competition or non-solicitation restriction),
    documents and information relating to his personal rights and obligations and his contact list; (iv) disclosing his post-employment
    restrictions in confidence in connection with any potential new employment or business venture; (v) disclosing documents and
    information in confidence to any attorney, financial advisor, tax preparer, or other professional for the purpose of securing
    professional advice provided that all of such professionals shall be bound by confidentiality no less restrictive than that
    set forth in this Section 13(e); (vi) using and disclosing documents and information at the request of the Company or its
    attorneys and agents; or (vii) using and disclosing documents and information in connection with good faith performance of
    his duties for the Company or any of its affiliates.


 


	 	(f)	Acknowledgement.
    Executive agrees and acknowledges that each restrictive covenant in this Section 13 is reasonable as to duration, terms and
    geographical area and that the same protects the legitimate interests of the Company, imposes no undue hardship on Executive,
    and is not injurious to the public.


 


	 	(g)	Survival.
    All of the restrictive covenants contained in this Section 13 shall be binding on the assigns, executors, administrators and
    other legal representatives of the Executive, and shall survive the termination of this Agreement and Executive’s employment.


 






    11


     


    

 


14.
INDEMNIFICATION. The Company agrees that (x) if Executive is made a party, or are threatened to be made a party, or reasonably
anticipates being made a party, to any threatened or actual action, suit or proceeding, whether civil, criminal, administrative,
investigative, appellate or other (a “Proceeding”) or (y) if any claim, dispute, demand, request, threat, discovery
request or request for testimony or information (a “Claim”) is made, or threatened to be made, by any person or entity,
and such Proceeding or Claim arises out of or relates to Executive’s positions with, or services for the Company or any
of its subsidiaries and affiliates, then Executive will promptly be indemnified and held harmless by the Company to the fullest
extent permitted by the Company’s plans, programs, agreements, arrangements or governing documents or, if greater, by applicable
law, against any and all costs, expenses, liabilities, and losses (including but not limited to attorneys’ fees and costs).
The Company will, in addition, advance to Executive, or pay directly, all costs and expenses incurred by Executive in connection
with any such Proceeding or Claim, or in connection with Executive’s seeking to enforce Executive’s rights under this
section, within fifteen (15) days after receiving written notice requesting such an advance and enclosing customary supporting
documentation, provided only that such notice includes an unsecured undertaking by Executive to repay the amount advanced if Executive
is ultimately determined, by a court of competent jurisdiction, not to be entitled to indemnification against such costs and expenses.
The foregoing rights to indemnification and advancement will continue indefinitely, whether or not Executive’s services
for the Company have terminated. Nothing herein shall limit any right that Executive may have in respect of indemnification, contribution,
advancement, or liability insurance coverage under any other plan, agreement, policy or arrangement of the Company or any of its
subsidiaries or affiliates, or under applicable law. A directors’ and officers’ liability insurance policy (or policies)
shall be kept in place, during the term of employment, providing coverage to Executive that is no less favorable to Executive
in any respect than the coverage then being provided to any other then current or former director or officer of the Company.


 


15.
INJUNCTIVE RELIEF. The Executive acknowledges that the precise value of the covenants in Section 13 are difficult to evaluate
and that no accurate measure of liquidated damages could possibly be established and therefore, in the event of a breach or threatened
breach of such provisions, the Company shall be entitled to temporary and permanent injunctive relief (without the position of
a bond or other security) restraining Executive from such breach or threatened breach. Notwithstanding anything to the contrary
herein, if any applicable law or governmental entity shall reduce the time period or scope during which the Executive shall be
prohibited from engaging in any competitive or soliciting activity described in Section 13, the period of time or scope, as the
case may be, for which the Executive shall be prohibited shall be reduced to the maximum time or scope permitted by law.


 


16.
NOTICES. Any notice required or permitted to be given pursuant to the provisions of this Agreement shall be sufficient
if in writing, and if personally delivered to the party to be notified or if sent by registered or certified mail to said party
at the following addresses:


 


	 	If
    to the Company:	Brain
    Scientific, Inc.
	 	 	205
    East 42nd Street
	 	 	14th
    Floor
	 	 	New
    York, New York 10017
	 	 	Attn:
    Board of Directors  
	 	 	 
	 	 With
    a copy to (which shall not constitute notice):
	 	 	Ruskin
    Moscou Faltischek, P.C.
	 	 	1425
    RXR Plaza
	 	 	East
    Tower, 15th Floor
	 	 	Uniondale,
    New York 11556
	 	 	Attn:
    Stephen E. Fox, Esq.
	 	 	 
	 	If
    to the Executive:	Boris
    Goldstein
	 	 	100
    U.N. Plaza, 7E
	 	 	New
    York, NY 10017




 






    12


     


    

 


17.
SEVERABILITY. In the event any portion of this Agreement is held to be invalid or unenforceable, the invalid or unenforceable
portion or provision shall not affect any other provision hereof and this Agreement shall be construed and enforced as if the
invalid provision had not been included.


 


18.
BINDING EFFECT. This Agreement shall inure to the benefit of and shall be binding upon the Company and upon any person,
firm or entity with which the Company may be merged or consolidated or which may acquire all or substantially all of the Company’s
assets through sale, lease, liquidation or otherwise, provided that the assignee or transferee contractually assumes the liabilities,
obligations and duties of the Company as contained in this Agreement. The rights and benefits of Executive are personal to him
and no such rights or benefits shall be subject to assignment or transfer by Executive.


 


19.
GOVERNING LAW, VENUE, INTERPRETATION OF LANGUAGE. The parties agree that this Agreement shall be governed by the laws of
the State of New York, without regard to conflict of laws principles, and that venue for any action between the parties that arises
out of this Agreement shall be in the County of New York, City of New York and State of New York. In the event an ambiguity or
question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this
Agreement.


 


20.
AMENDMENT AND MODIFICATION. All terms, conditions and provisions of this Agreement shall remain in full force and effect
unless modified, changed, altered or amended, in writing, executed by both parties.


 


21.
INDEPENDENT LEGAL ADVICE. The Executive acknowledges that he has been advised to seek independent legal counsel in respect
of the Agreement and the matters contemplated herein. To the extent that he declines to receive independent legal counsel in respect
of the Agreement, he waives the right, should a dispute later develop, to rely on his lack of independent legal counsel to avoid
his obligations, to seek indulgences from the Company or to otherwise attack the integrity of the Agreement and the provisions
thereof, in whole or in part.


 


22.
COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original
as against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument.
This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures
of all of the parties reflected hereon as the signatories. Delivery of an executed counterpart of this Agreement electronically
or by facsimile shall be effective as delivery of an original executed counterpart of this Agreement.


 


23.
ENTIRE AGREEMENT. This Agreement constitutes the entire agreement between the parties and supersedes and replaces any prior
agreement; and there are no other agreements between the parties with respect to the subject matter contained herein except as
set forth herein.


 


[Signatures
follow on next page]


 






    13


     


    

 


IN
WITNESS WHEREOF, the parties hereto have set their hands and seals effective on the day and year first above written.


 


	 	Brain
    Scientific Inc.
	 	 
	 	 
	 	Name:
    Vadim Sakharov
	 	Title:
CTO and President
	 	 
	 	 
	 	Boris
    (Baruch) Goldstein